Paid Clinical Trials - 82,000 Members & Growing

  • Paid Clinical Trials
  • About Us
  • Auto-Updates
  • FAQ's
  • Quick Start Guide
www.GlobalTestMarket.com

 

Find Paid Clinical Trials Join Paid Clinical Trials ...

PaidClinicalTrials.org is a registry of compensated and uncompensated, federally and privately supported clinical trials conducted in the United States and around the world. Here you will find information about a trial's purpose, who may participate, locations, and phone numbers.

 

Find Paid Clinical Trials Clinical Trial Seekers - PCT is a public service, sponsor supported, clinical trial database that may be accessed by the general public at no charge in accordance with our terms of service use.

Clinical trials are added and removed each day on a 30 day rotation. For accuracy - We only list clinical trials that have been reported to these government agencies in the last 30 days:

 

U.S. National Library of Medicine,
U.S. Department of Health & Human Services
U.S. National Institutes of health Services.







Paid Clinical Trials - Auto Update Service

If you would like to receive timely and important notifications about new clinical trials in your area please fill out this short form. There is never any cost for our notification services. We value your privacy, your email address and member information is NEVER shared!

*  Your Email Address:
*  Preferred Format:
    Title:
    First Name:
    Country:
    State (US):
    City (UK):
    Territory (AU):

Tips for Finding Clinical Trials

 

One of the toughest and most-time consuming parts for medical research staff conducting the clinical trials is actually finding volunteers willing to participate. Research staff are looking for you! There are numerous ways to identify clinical trials looking for healthy human volunteers.

 

Trials are actively conducted by hospitals, universities, foundations, and contract research organizations (CROs, firms that conduct studies for big pharmaceutical and biotechnology companies). According to CISCRP, nearly 40% of these clinical trials can be learned about through media such as tv, radio, or printed ads. While finding studies through tv and radio ads might be difficult, you can actively scour the wanted section of your local newspapers to find trials.

Most local research clinics run ads for volunteers in the local newspaper, employment papers, on TV, and on the radio. They also post ads on Craigslist and on their own websites. Call them up as soon as you see something of interest. If the study is no longer recruiting volunteers, they might enter you in there database for future study participation.

 

Look up local research clinics in your phone book and ask (a) if they have any studies openly recruiting healthy volunteers and (b) if you could be entered into their volunteer database.

College campuses and major universities with research hospitals are also great places to find clinical trial. Schools of medicine, dentistry, and nursing, along with departments of psychology, sociology, and communications, at local universities, are always looking for willing volunteers for their experiments. Perform an internet search for the hospitals, schools, and departments on nearby campuses, then look for any section concerning clinical trials or research volunteers.


When searching for clinical trials on our website you will click on a Clinical Trial Information sheet like this example. Find Paid Clinical Trials Example Information Sheet. The first thing you should do is to see if the clinical trial is right for you. You can do this by quickly scanning the headings of the information sheet. These headings are highlighted on the left by blue icons as follows:


  >> Status of the Clinical Trial (This will appear at the top in red or green)


Purpose - This will briefly let you know about the clinical trial and how it is conducted.


Eligibility - This tells you age, gender and health status information. If you do not meet these eligibility requirement you should move to another clinical trial.


Contacts and Locations - This will list the locations the clinical trial is being conducted and it will usually list the contact person to call. Note - Even if your location is not listed you should call the clinical trial investigator. Sometimes their locations have not been updated or they are willing to pay time and travel expenses.


More Information - This will often give alternative contact people and other pertinent information about the trial.

These headings appear on the left side of the information sheet and are fairly self explanatory. Doing this will help you to quickly evaluate if the clinical trial is right for you.

 


 

Paid Clinical Trials Searching Tips

 

Paid Clinical Trials Check the Conditions Category - If you only search the "Locations" directory you are missing out on a lot of clinical trials. Trials that are listed by "Condition" usually have multiple locations and can add new locations as the study moves forward.

 

Paid Clinical Trials Register Your Profile with us. - You can post your location and condition in our personal clinical trials directory for FREE. This helps the research recruiters find you when the right trial becomes available. Register for Clinical Trials Here.

 

Paid Clinical Trials Call the Clinical Trial Recruiters - At the bottom of all the information sheets you will see a "Contact Information" heading. Many clinical trials can be conducted in remote locations and the recruiters can help you.

 

Paid Clinical Trials Subscribe to our Auto Update Service - By subscribing to our Auto Update Service you will receive automated emails informing you when new trials have opened in your area.

Sponsored Links







  • Condition:   Alcohol Drinking
    Intervention:   Behavioral: Experimental Mindset Induction
    Sponsor:   University of Konstanz
    Recruiting

  • Conditions:   Intimate Partner Violence;   Domestic Abuse;   Drug and Alcohol Abuse
    Intervention:   Behavioral: Intervention to address family violence and drug and alcohol misuse
    Sponsors:   Australian National University;   University of Peradeniya;   Department of Foregin Affairs and Trade, Australia
    Not yet recruiting

  • Conditions:   Alcohol Dependence;   Alcohol-Related Disorders
    Interventions:   Behavioral: Episodic Future Thinking (EFT);   Behavioral: Episodic Recent Thinking (ERT)
    Sponsor:   Addiction Recovery Research Center
    Recruiting

  • Conditions:   Alcohol Drinking;   Violence
    Interventions:   Behavioral: Step 1 Treatment BI+HC;   Behavioral: Step 1 Treatment BI+TM;   Behavioral: Step 2 Treatment Responders;   Behavioral: Step 2 Treatment Non-Responders
    Sponsors:   University of Michigan;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Not yet recruiting

  • Conditions:   Alcohol Drinking;   Alcohol Consumption, Youth
    Interventions:   Other: Personalized Feedback Intervention with Values;   Other: Personalized Feedback Intervention Traditional
    Sponsor:   Oklahoma State University
    Recruiting

  • Condition:   Alcohol Dependence
    Interventions:   Behavioral: active approach avoidance training and sham visual probe training;   Behavioral: sham approach avoidance training and active visual probe training;   Behavioral: active approach avoidance training and active visual probe training;   Behavioral: sham approach avoidance training and sham visual probe training
    Sponsors:   University Ghent;   PZ Heilig Hart;   PZ Sint-Camillus;   University of Amsterdam
    Recruiting

  • Condition:   Alcohol Use Disorder
    Interventions:   Behavioral: Psychoeducational Group Intervention on Alcohol Drinking Related to Stress;   Behavioral: Cognitive Training
    Sponsors:   University of Konstanz;   Centre for Psychiatry Reichenau, Germany
    Recruiting

  • Condition:   Alcohol Disorders
    Intervention:   Other: cognitive remediation
    Sponsor:   University Hospital, Caen
    Not yet recruiting

  • Condition:   Alcohol Drinking in College
    Interventions:   Behavioral: Induction of Implemental Mindset;   Behavioral: Induction of Deliberative Mindset
    Sponsor:   University of Konstanz
    Not yet recruiting

  • Conditions:   Alcohol Use Disorder;   Nicotine Use Disorder
    Intervention:   Behavioral: magnetic resonance imaging (MRI)
    Sponsor:   Oregon Health and Science University
    Not yet recruiting

  • Condition:   Alcohol Drinking
    Interventions:   Drug: Mavoglurant;   Drug: Placebo
    Sponsor:   Yale University
    Not yet recruiting

  • Conditions:   Alcohol Drinking;   Alcohol Intoxication;   Alcohol Impairment;   Drive;   Driving Impaired;   Driving Under the Influence;   Behavior, Drinking
    Interventions:   Behavioral: Loss-framed text message;   Behavioral: Gain-Framed text message
    Sponsor:   University of Pennsylvania
    Not yet recruiting

  • Condition:   Alcohol Use Disorder
    Interventions:   Drug: Beer;   Device: Videotaped drinking session
    Sponsor:   University of Florida
    Recruiting

  • Conditions:   Gambling;   Alcohol Consumption
    Interventions:   Behavioral: Gambling Internet Intervention;   Behavioral: Check Your Drinking
    Sponsors:   Centre for Addiction and Mental Health;   University of Calgary;   University of Manitoba
    Not yet recruiting

  • Conditions:   Alcohol and Substance-Related Mental Disorders;   Sexually Transmitted Diseases
    Interventions:   Behavioral: Brief Intervention (BI) with Technology Extender;   Other: Brochure
    Sponsors:   The Miriam Hospital;   Planned Parenthood of Southern New England;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Diabetes;   Endocrine System Diseases;   Gastro-Intestinal Disorder;   Neuro-Degenerative Disease;   Epilepsy;   Autoimmune Diseases;   Renal Disease;   Cardiac Disease;   Metabolic Disease;   Genetic Diseases, Inborn;   Respiratory Disease;   Hematologic Diseases;   Autism Spectrum Disorder;   Fetal Alcohol Spectrum Disorders;   Traumatic Brain Injury;   Stroke
    Interventions:   Other: Patient Navigator;   Other: Usual Care
    Sponsors:   University of Calgary;   Alberta Health Services;   University of Alberta
    Not yet recruiting

  • Condition:   Diabetes Mellitus, Type 1
    Intervention:   Other: Mixed meal with different macronutrient composition
    Sponsors:   Jorge Bondia;   Hospital Francesc de Borja, Gandia, Spain;   Spanish Ministry of Economy, Industry and Competitiveness
    Not yet recruiting

  • Conditions:   Pain;   Alcohol Drinking;   Acute Pain;   Drinking Behavior
    Interventions:   Drug: Low Alcohol;   Drug: Moderate Alcohol;   Drug: Placebo Alcohol;   Other: Pain Induction;   Other: No Pain Induction
    Sponsors:   Syracuse University;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Condition:   Familial Alcoholism Vulnerability
    Interventions:   Drug: Mavoglurant (AFQ056);   Other: Placebo
    Sponsor:   Yale University
    Not yet recruiting

  • Conditions:   Tuberculosis;   HIV/AIDS;   Alcohol Abuse
    Interventions:   Drug: Isoniazid 300 Mg ORAL TABLET;   Drug: Pyridoxine 25 Mg Oral Tablet
    Sponsors:   University of California, San Francisco;   Boston University;   Boston Medical Center;   Mbarara University of Science and Technology
    Recruiting

  • Condition:   Alcohol Drinking
    Intervention:   Other: SSL Implementation Strategy
    Sponsors:   Rhode Island Hospital;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Not yet recruiting

  • Condition:   Alcohol Drinking
    Interventions:   Drug: Alcohol (Oral);   Drug: Alcohol (IV);   Drug: Alcohol (Ethanol)
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Not yet recruiting

  • Conditions:   Suicide, Attempted;   Drug Use;   Alcohol; Use, Problem
    Interventions:   Behavioral: Brief intervention to prevent suicide attempt;   Behavioral: Enhanced treatment as usual
    Sponsors:   University of Rochester;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Not yet recruiting

  • Conditions:   Alcohol Use Disorder;   Alcohol Withdrawal
    Interventions:   Drug: Diazepam 10 MG;   Drug: Baclofen 30mg;   Drug: Baclofen 60mg
    Sponsor:   Universitair Ziekenhuis Brussel
    Recruiting

  • Conditions:   Alcohol Use Disorder;   Depressive Disorder;   Cigarette Smoking
    Intervention:   Device: Intermittent theta burst transcranial magnetic stimulation
    Sponsor:   Stanford University
    Not yet recruiting

  • Condition:   Alcoholic Intoxication
    Interventions:   Device: Active tDCS stimulations;   Device: Sham tDCS
    Sponsor:   Centre Hospitalier Henri Laborit
    Recruiting

  • Conditions:   HIV Infection;   Alcohol Use;   Pain
    Interventions:   Drug: Low dose naltrexone;   Drug: Nalmefene
    Sponsors:   Boston Medical Center;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Not yet recruiting

  • Conditions:   Generalized Anxiety Disorder;   Panic Disorder;   Social Anxiety;   Alcohol Use Disorder
    Intervention:   Behavioral: Computer-based VC-CBT
    Sponsor:   University of Minnesota - Clinical and Translational Science Institute
    Not yet recruiting

  • Condition:   Alcohol Dependence
    Interventions:   Behavioral: Self Match;   Behavioral: Ekspert Match
    Sponsor:   Kjeld Andersen
    Recruiting

  • Condition:   Alcohol Use Disorder
    Interventions:   Drug: Lacosamide;   Drug: Placebo oral capsule
    Sponsors:   Boston Medical Center;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Not yet recruiting

  • Conditions:   Drinking Heavy;   Drinking Behavior;   Drinking Excessive
    Interventions:   Behavioral: Motivational Enhancement Therapy and Strengths Based Case Management (MET/SBCM);   Other: Alcohol education brochure
    Sponsors:   University of California, Los Angeles;   University of California, San Diego;   Providence Health & Services;   Northeastern University
    Not yet recruiting

  • Conditions:   Opioid-use Disorder;   Harmful; Use, Alcohol
    Intervention:   Drug: Nalmefene
    Sponsors:   Yale University;   First Pavlov State Medical University in St. Petersburg, Russia
    Recruiting

  • Conditions:   Major Depression;   Alcohol Use Disorder
    Interventions:   Drug: allogeneic human mesenchymal stem cells (allo-hMSCs);   Drug: Placebo
    Sponsors:   Joshua M Hare;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Liver Diseases, Alcoholic;   Fibrosis
    Interventions:   Diagnostic Test: transient elastography;   Diagnostic Test: Enhanced liver fibrosis test;   Diagnostic Test: Indirect serum markers of liver fibrosis;   Diagnostic Test: Direct serum markers of liver fibrosis;   Diagnostic Test: LiverTRAIL;   Diagnostic Test: Cytokeratin 18;   Diagnostic Test: Omics markers
    Sponsors:   Maja Thiele;   European Commission, H2020;   Novo Nordisk A/S;   University of Southern Denmark;   Esbjerg University Hospital of South-West Jutland;   Odense Municipality Alcohol Rehabilitation Unit;   Svendborg Municipality Alcohol Rehabilitation Unit;   University of Copenhagen;   University of Oslo;   Nordic Bioscience A/S;   VLV Bio, Peviva AB;   Manatee APS;   Siemens Healthcare A/S;   Steno Diabetes Center;   Biomedical Research Foundation, Academy of Athens;   European Molecular Biology Laboratory, EMBL, University of Heidelberg
    Recruiting

  • Conditions:   CRAFT;   Concern Significant Others;   Alcohol Use Disorder
    Intervention:   Behavioral: CRAFT
    Sponsor:   Kjeld Andersen
    Not yet recruiting

  • Condition:   Alcohol Use Disorder
    Intervention:   Behavioral: Drinking Options - Motivate, Shared Decisions, Telemonitor (DO-MoST)
    Sponsor:   VA Office of Research and Development
    Not yet recruiting

  • Condition:   Alcoholic Liver Disease
    Intervention:   Other: survey
    Sponsor:   Nicole T Shen
    Recruiting

  • Condition:   Alcohol Use Disorder
    Intervention:   Drug: Pregabalin
    Sponsor:   New York State Psychiatric Institute
    Not yet recruiting

  • Condition:   Alcohol Use Disorder
    Interventions:   Other: Placebo;   Other: Phytocannabinoid cannabidiol (CBD)
    Sponsors:   New York University School of Medicine;   National Institutes of Health (NIH)
    Not yet recruiting

  • Condition:   Alcoholic Liver Disease
    Intervention:   Other: standard therapy
    Sponsor:   Nanfang Hospital of Southern Medical University
    Not yet recruiting

  • Condition:   Binge Drinking, Underage Drinking, Drinking and Driving, Alcohol-Related Harms
    Intervention:   Behavioral: GSDG multi-component intervention
    Sponsor:   HBSA
    Recruiting

  • Condition:   Alcohol Abuse
    Interventions:   Behavioral: Enhanced Intervention;   Behavioral: Standard Intervention
    Sponsors:   Brown University;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Not yet recruiting

  • Condition:   Alcohol Drinking
    Intervention:   Other: All Participants
    Sponsor:   Butler Hospital
    Not yet recruiting

  • Conditions:   Alcohol Use Disorder;   Post Traumatic Stress Disorder
    Interventions:   Drug: Cannabidiol;   Drug: Placebos
    Sponsors:   New York University School of Medicine;   National Institutes of Health (NIH)
    Not yet recruiting

  • Condition:   Alcohol Intoxication
    Intervention:   Diagnostic Test: LabPatch-alcohol
    Sponsor:   Mclean Hospital
    Not yet recruiting

  • Condition:   Posttraumatic Stress Disorder
    Intervention:  
    Sponsors:   RTI International;   Womack Army Medical Center;   Tripler Army Medical Center;   Landstuhl Regional Medical Center
    Not yet recruiting

  • Conditions:   Alcohol Use Disorder;   Inflammation;   Neurocognitive Dysfunction;   Craving;   Alcohol Drinking
    Interventions:   Drug: Minocycline;   Drug: Sugar pill
    Sponsors:   University of California, Los Angeles;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Not yet recruiting

  • Conditions:   Alcohol Drinking;   Control
    Interventions:   Drug: N-Acetylcysteine;   Drug: Placebo Oral Capsule
    Sponsors:   Medical University of South Carolina;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Cocaine Dependence;   Alcohol Dependence
    Interventions:   Device: Real cTBS;   Device: Sham cTBS
    Sponsors:   Medical University of South Carolina;   National Institute on Drug Abuse (NIDA)
    Recruiting

  • Conditions:   Alcohol Dependence, in Remission;   Addiction, Alcohol
    Interventions:   Drug: Exenatide 2 MG Injection;   Drug: BD PosiFlush (saline)
    Sponsors:   Anders Fink-Jensen, MD, DMSci;   The Novavì outpatient clinics, Copenhagen;   Neurobiology Research Unit, Rigshospitalet, Copenhagen;   Section of Biostatistics University of Copenhagen, Copenhagen
    Recruiting

  • Conditions:   Alcohol Use Disorder;   Anxiety Disorders
    Interventions:   Behavioral: Unified Protocol for Transdiagnostic Treatment of Emotional Disorders;   Behavioral: Take Control
    Sponsor:   Boston University Charles River Campus
    Not yet recruiting

  • Condition:   HIV/AIDS
    Intervention:   Behavioral: WELL Program
    Sponsors:   Louisiana State University Health Sciences Center in New Orleans;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Alcohol Dependence;   Alcohol Withdrawal Syndrome;   Trauma;   Heavy Drinking;   Alcohol Use Disorder
    Interventions:   Drug: Valproate;   Drug: Lorazepam
    Sponsor:   CAMC Health System
    Recruiting

  • Condition:   Alcohol Use Disorder
    Interventions:   Drug: Alcohol;   Drug: Placebos;   Drug: N-acetyl cysteine
    Sponsors:   William Stoops;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Condition:   Alcoholism
    Interventions:   Dietary Supplement: Ketogenic Diet (KD);   Dietary Supplement: Standard American (SA) Meals and Shakes
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Liver Failure;   Liver Diseases, Alcoholic;   Liver Diseases;   Pain, Postoperative;   Transplant; Failure, Liver;   Liver Cirrhosis, Biliary
    Intervention:   Device: BRIDGE device
    Sponsor:   Duke University
    Not yet recruiting

  • Condition:   Substance Abuse
    Intervention:   Behavioral: Coaching
    Sponsor:   VA Office of Research and Development
    Recruiting

  • Conditions:   Alcohol Use Disorder;   Bipolar Disorder
    Interventions:   Drug: N-Acetylcysteine;   Drug: Gabapentin;   Drug: Placebo Oral Tablet
    Sponsors:   Medical University of South Carolina;   National Institutes of Health (NIH);   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Binge Drinking;   Unsafe Sex;   HIV/AIDS;   Sexually Transmitted Diseases
    Interventions:   Other: Alcohol Administration;   Other: Placebo Alcohol Administration;   Other: No Alcohol Administration
    Sponsor:   Brown University
    Recruiting

  • Conditions:   Opioid-use Disorder;   Alcohol Use Disorder
    Intervention:   Drug: Gabapentin
    Sponsor:   New York State Psychiatric Institute
    Recruiting

  • Condition:   Alcoholism
    Interventions:   Behavioral: Individualized Assess & Treatment (IATP);   Behavioral: Packaged Cognitive-Behavioral (PCBT);   Behavioral: Case Management (CaseM)
    Sponsors:   UConn Health;   Ronald M. Kadden;   Howard Tennen
    Recruiting

  • Conditions:   Depressive Disorder;   Anxiety Disorder;   Somatoform Disorder;   Alcohol Use Disorder
    Intervention:   Other: collaborative and stepped care model
    Sponsors:   Universitätsklinikum Hamburg-Eppendorf;   Center for Health Care Research Hamburg;   Hamburg Center for Health Economics
    Not yet recruiting

  • Conditions:   Alcohol Abuse;   Post-Traumatic Stress Disorder
    Interventions:   Behavioral: VetChange;   Behavioral: web-based drinking assessment and feedback tool (AFT)
    Sponsor:   Eric Kuhn
    Not yet recruiting

  • Condition:   Alcohol Dependence
    Intervention:  
    Sponsor:   Marie-Pierre TAVOLACCI
    Recruiting

  • Condition:   Alcohol Use Disorder
    Interventions:   Device: Active rTMS;   Device: Sham rTMS
    Sponsor:   VA Office of Research and Development
    Not yet recruiting

  • Conditions:   College Student Drinking;   Eating Disorder;   Stress, Psychological;   Burn Out Syndrome;   Cigarette Smoking;   Hyperactivity;   Health Behavior;   Impulsive Behavior
    Intervention:  
    Sponsor:   Marie-Pierre TAVOLACCI
    Recruiting

  • Conditions:   Alcohol Use Disorder;   Post Traumatic Stress Disorder
    Intervention:   Other: Computerized Plasticity-Based Adaptive Cognitive Training
    Sponsors:   Posit Science Corporation;   VA Palo Alto Health Care System
    Not yet recruiting

  • Condition:   Alcohol Addiction
    Intervention:   Device: Soberlink Cellular Device
    Sponsors:   Soberlink Healthcare LLC;   MAP Health Management LLC
    Recruiting

  • Conditions:   Sexual Assault and Rape;   Risk Behavior;   Alcohol Abuse
    Interventions:   Other: Social Norms Questionnaire;   Other: Standardized Interview;   Other: Group Discussion
    Sponsors:   Womack Army Medical Center;   Rhode Island Hospital;   University of North Carolina, Charlotte
    Recruiting

  • Condition:   ALD - Alcoholic Liver Disease
    Intervention:   Other: Blood draw
    Sponsor:   The Cleveland Clinic
    Recruiting

  • Condition:   PTSD and Alcohol Use Disorder
    Interventions:   Drug: topiramate;   Behavioral: prolonged exposure;   Drug: placebo
    Sponsors:   VA Office of Research and Development;   University of California, San Diego
    Recruiting

  • Condition:   Alcohol Use Disorder
    Interventions:   Drug: Apremilast;   Drug: Placebo
    Sponsors:   The Scripps Research Institute;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Depression;   Anxiety;   Somatoform Disorders;   Alcohol Abuse
    Intervention:  
    Sponsors:   Charite University, Berlin, Germany;   German Federal Ministry of Education and Research
    Recruiting

  • Condition:   Alcoholic Liver Disease
    Intervention:   Other: Biopsies
    Sponsor:   The Cleveland Clinic
    Recruiting

  • Condition:   Alcohol Abuse
    Interventions:   Other: Alcoholic Beverage;   Other: Non-Alcoholic Beverage;   Drug: Ethanol
    Sponsor:   Yale University
    Recruiting

  • Conditions:   Cardiovascular Diseases;   Diabetes
    Intervention:   Other: Alcohol
    Sponsors:   Beth Israel Deaconess Medical Center;   National Institute on Alcohol Abuse and Alcoholism (NIAAA);   Harvard School of Public Health;   Wake Forest University Health Sciences;   Julius Center
    Not yet recruiting

  • Condition:   Alcohol Abuse
    Interventions:   Drug: Bupropion;   Drug: Placebo Oral Tablet
    Sponsors:   University of North Carolina, Chapel Hill;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Substance Abuse;   Risk Reduction;   RIsky Sexual Behavior
    Interventions:   Behavioral: Handbook condition;   Behavioral: Handbook plus condition
    Sponsor:   Washington State University
    Recruiting

  • Condition:   Veisalgia
    Interventions:   Drug: JMI-001;   Drug: Naproxen;   Drug: Fexofenadine;   Drug: placebo
    Sponsor:   JMI Capital Group
    Not yet recruiting

  • Condition:   Hepatic Steatosis
    Intervention:   Drug: VLX103
    Sponsors:   University of Massachusetts, Worcester;   The Cleveland Clinic;   University of Texas Southwestern Medical Center;   University of Louisville
    Recruiting

  • Condition:   Alcoholism
    Intervention:  
    Sponsors:   National Institute on Alcohol Abuse and Alcoholism (NIAAA);   National Institute on Drug Abuse (NIDA);   The Peter G. Dodge Foundation (PGDF)
    Recruiting

  • Condition:   Hepatocellular Carcinoma Non-resectable
    Intervention:   Procedure: Percutaneous ethanol alcohol injection
    Sponsor:   The National Ribat University
    Recruiting

  • Condition:   Alcohol Use Disorder
    Interventions:   Other: Affective Training;   Other: Neutral Training
    Sponsors:   University of Florida;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Condition:   Hepatocellular Carcinoma
    Intervention:   Procedure: Combined Treatment
    Sponsor:   The National Ribat University
    Recruiting

  • Condition:   Alcoholism
    Interventions:   Drug: Topiramate and N-Acetyl Cysteine;   Drug: Topiramate and Placebo
    Sponsor:   Nassima Ait-Daoud Tiouririne
    Recruiting

  • Condition:   Cancer
    Intervention:   Behavioral: Tailored knowledge translation
    Sponsors:   McMaster University;   Canadian Institutes of Health Research (CIHR)
    Not yet recruiting

  • Condition:   Alcohol; Harmful Use
    Intervention:   Behavioral: E-alcohol therapy
    Sponsors:   University of Southern Denmark;   TRYG Foundation;   Novavi Outpatient Clinics
    Not yet recruiting

  • Conditions:   Alcohol Drinking;   Alcohol Use Disorder;   Alcohol Abstinence
    Interventions:   Dietary Supplement: kudzu extract, puerarin;   Dietary Supplement: Placebo control
    Sponsor:   Mclean Hospital
    Not yet recruiting

  • Condition:   Psychomotor Impairment
    Interventions:   Drug: delta 9 tetrahydrocannabinol;   Drug: placebo delta 9 tetrahydrocannabinol;   Drug: Alcohol;   Drug: Placebo alcohol
    Sponsors:   Centre for Addiction and Mental Health;   Canadian Institutes of Health Research (CIHR);   Health Canada
    Recruiting

  • Condition:   Alcoholic Hepatitis
    Intervention:   Drug: Methylprednisolone or placebo
    Sponsor:   Erasme University Hospital
    Not yet recruiting

  • Condition:   Alcoholic Hepatitis
    Intervention:   Drug: Combined Vancomycin and Gentamycin and Meropenem
    Sponsor:   University of Aarhus
    Recruiting

  • Conditions:   Smoking;   Heavy Episodic Drinking
    Interventions:   Behavioral: Tobacco Status Project Intervention;   Behavioral: Tobacco Status Project + Alcohol Intervention;   Drug: nicotine patch
    Sponsors:   University of California, San Francisco;   National Institute on Drug Abuse (NIDA)
    Not yet recruiting

  • Conditions:   HBV;   Alcoholic Hepatitis;   Liver Fibroses
    Intervention:   Other: Estimates - prevalence of lifetime/chronic HBV infection
    Sponsors:   University of Alabama at Birmingham;   University Teaching Hospital;   Tropical Gastroenterology and Nutrition Group;   Centre for Infectious Disease Research in Zambia;   Ministry of Health, Zambia
    Recruiting

  • Condition:   Unhealthy Alcohol Use
    Interventions:   Behavioral: Contingency Management Counseling;   Behavioral: Addiction Physician Management;   Behavioral: Motivational Enhancement Therapy
    Sponsors:   Yale University;   VA Connecticut Healthcare System;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Not yet recruiting

  • Conditions:   Nausea;   Vomiting
    Interventions:   Other: Inhaled Isopropyl Alcohol (IPA);   Drug: Oral Dissolvable Tablet Zofran (ondansetron)
    Sponsor:   Texas Tech University Health Sciences Center, El Paso
    Recruiting

  • Condition:   HIV Infections
    Interventions:   Behavioral: YouTHrive;   Behavioral: Thrive Tips
    Sponsors:   University of Minnesota - Clinical and Translational Science Institute;   University of North Carolina;   University of Michigan;   Emory University;   Children's Hospital of Philadelphia;   Texas Children's Hospital;   Cook County Hospital;   Montefiore Medical Center;   University of South Florida
    Recruiting

  • Condition:   Alcoholic Liver Disease
    Intervention:   Radiation: MRI
    Sponsor:   The Cleveland Clinic
    Recruiting

  • Condition:   Acute Alcohol Intoxication
    Interventions:   Other: Personalized Normative Feedback;   Other: Brief Therapeutic Intervention;   Other: Evaluation questionnaire
    Sponsor:   Rennes University Hospital
    Not yet recruiting

  • Condition:   Alcohol Dependence
    Interventions:   Procedure: Advanced Nurse (AN);   Procedure: General Practitioner (GP)
    Sponsors:   University Hospital, Lille;   Ministry of Health, France
    Recruiting

  • Conditions:   Alcohol Use Disorder;   Anxiety Disorder/Anxiety State;   Stress Disorder;   HPA;   Drinking to Cope
    Intervention:  
    Sponsors:   University of Minnesota - Clinical and Translational Science Institute;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Not yet recruiting

  • Condition:   Alcohol Use
    Interventions:   Drug: Oxytocin;   Drug: Placebo
    Sponsor:   Medical University of South Carolina
    Recruiting

  • Condition:   Alcohol-Related Disorders
    Interventions:   Other: Melatonin;   Other: Placebo
    Sponsor:   Centre for Addiction and Mental Health
    Recruiting

  • Condition:   Alcohol Use Disorder
    Interventions:   Other: [11C]-(+)-PHNO PET scan;   Other: Alcohol Self-Administration;   Other: Craving Task;   Other: MRI scan;   Other: Neuropsychological Assessment
    Sponsor:   Centre for Addiction and Mental Health
    Recruiting

  • Conditions:   Domestic Violence;   Alcohol Consumption
    Interventions:   Drug: Alcohol beverage;   Drug: Placebo beverage
    Sponsors:   University of New Mexico;   The Mind Research Network
    Recruiting

  • Condition:   Alcohol Use Disorder
    Interventions:   Drug: Varenicline;   Drug: Placebo oral capsule
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Condition:   Alcoholism
    Intervention:   Drug: Pioglitazone
    Sponsors:   Emory University;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Condition:   Alcohol Use Disorder
    Interventions:   Drug: Topiramate;   Drug: placebo
    Sponsor:   VA Office of Research and Development
    Recruiting

  • Conditions:   Smoking Cessation;   Alcohol Drinking
    Interventions:   Drug: Nicotine Replacement Therapy;   Drug: Bupropion;   Behavioral: Cognitive Behavioral Treatment;   Behavioral: Mobile Contingency Management
    Sponsor:   Duke University
    Recruiting

  • Condition:   Antisocial Behavior
    Interventions:   Behavioral: Multisystemic Therapy-Emerging Adults;   Behavioral: Enhanced Treatment as Usual
    Sponsors:   Oregon Social Learning Center;   University of Massachusetts, Worcester
    Recruiting

  • Conditions:   Alcohol Drinking;   Cigarette Smoking Toxicity
    Intervention:   Drug: Reduced nicotine cigarettes
    Sponsor:   Battelle Memorial Institute
    Not yet recruiting

  • Conditions:   Alcohol Drinking;   Marijuana
    Interventions:   Drug: THC 7.2%;   Drug: THC 3.0%;   Drug: Placebo
    Sponsors:   Brown University;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Condition:   Alcohol Dependence
    Interventions:   Behavioral: Alc-IT (50/50) (morning);   Behavioral: Alc-IT (75/25) (morning);   Behavioral: Control-training (morning);   Behavioral: Alc-IT (50/50) (afternoon);   Behavioral: Alc-IT (75/25) (afternoon);   Behavioral: Control-training (afternoon)
    Sponsors:   University of Bern;   Clinic Südhang;   Forel Clinic
    Recruiting

  • Conditions:   Post Traumatic Stress Disorder (PTSD);   Addiction;   Alcohol Abuse
    Interventions:   Drug: N-Acetylcysteine (NAC) Treatment;   Behavioral: Cognitive Behavioral Therapy;   Drug: Placebo Oral Capsule
    Sponsors:   Medical University of South Carolina;   National Institute on Alcohol Abuse and Alcoholism (NIAAA);   National Institutes of Health (NIH)
    Recruiting

  • Condition:   Alcohol Drinking
    Interventions:   Drug: Saracatinib;   Drug: Placebos
    Sponsor:   Yale University
    Recruiting

  • Condition:   Mild to Heavy Alcohol Consumption
    Intervention:   Other: Oxycodone
    Sponsors:   University of Washington;   National Institutes of Health (NIH);   National Institute on Aging (NIA);   Seattle Institute for Biomedical and Clinical Research
    Recruiting

  • Conditions:   HIV Positive;   Alcohol Use
    Interventions:   Behavioral: Computerized Brief Intervention (CBI);   Behavioral: CBT4CBT;   Drug: Recommendation and Counseling for Alcohol Pharmacotherapy
    Sponsor:   University of Alabama at Birmingham
    Not yet recruiting

  • Conditions:   Alcohol Use Disorder;   PTSD;   Cognitive Dysfunction
    Interventions:   Behavioral: Cognitive Training;   Behavioral: Cognitive training placebo control
    Sponsor:   VA Office of Research and Development
    Recruiting

  • Conditions:   HIV;   Partner Violence;   Malnutrition;   Alcohol Use/Abuse;   Depression
    Interventions:   Behavioral: Accountable Condition;   Behavioral: Control Condition
    Sponsors:   University of California, Los Angeles;   National Institute of Mental Health (NIMH);   University of Stellenbosch
    Recruiting

  • Condition:   Alcoholic Hepatitis
    Interventions:   Drug: standard medical therapy;   Drug: G-CSF;   Drug: n-Acetylcysteine
    Sponsor:   Postgraduate Institute of Medical Education and Research
    Recruiting

  • Conditions:   Self-regulation;   Adolescents;   Fetal Alcohol Spectrum Disorder
    Intervention:   Behavioral: Self-Regulation Intervention adapted from the Alert Program ®
    Sponsors:   University of Alberta;   Glenrose Rehabilitation Hospital;   Woman and Children's Health Research Institute;   NeuroDevNet;   Provincial Health Services Authority;   University of British Columbia
    Recruiting

  • Condition:   Alcohol Dependence
    Interventions:   Drug: Zonisamide;   Behavioral: Take Control;   Drug: Placebo (for Zonisamide)
    Sponsors:   Boston University Charles River Campus;   Mclean Hospital;   University of Houston
    Not yet recruiting

  • Conditions:   Alcoholism;   Substance-Related Disorders
    Interventions:   Drug: intranasal oxytocin spray;   Other: intranasal spray without oxytocin
    Sponsors:   Norwegian University of Science and Technology;   St. Olavs Hospital;   Lade Addiction Treatment Center
    Recruiting

  • Conditions:   HIV;   Alcohol Use Disorders
    Intervention:   Other: Transitional HIV care for prison releasees
    Sponsors:   University of North Carolina, Chapel Hill;   National Institutes of Health (NIH);   John E. Fogarty International Center (FIC)
    Recruiting

  • Conditions:   Posttraumatic Stress Disorder (PTSD);   Alcohol Use Disorder (AUD);   Substance Use Disorder (SUD)
    Interventions:   Drug: N-acetylcysteine;   Drug: Placebo;   Behavioral: Cognitive behavioral therapy
    Sponsors:   Medical University of South Carolina;   United States Department of Defense;   Institute for Translational Neuroscience
    Recruiting

  • Condition:   Alcohol Dependence
    Intervention:  
    Sponsor:   University Hospital, Lille
    Recruiting

  • Condition:   Alcohol Use Disorder
    Intervention:   Device: MRI: Brain Imaging data collection
    Sponsor:   University of Minnesota - Clinical and Translational Science Institute
    Recruiting

  • Conditions:   PTSD;   Alcohol Use Disorder
    Interventions:   Drug: Pregabalin plus BBCET;   Other: Placebo plus BBCET
    Sponsors:   University of Maryland;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Smoking Cessation;   Alcohol Drinking
    Interventions:   Drug: Chantix;   Behavioral: Behavioral Counseling Sessions;   Drug: NicodermCQ
    Sponsors:   University of Chicago;   Pfizer
    Not yet recruiting

  • Conditions:   Tuberculosis;   Alcohol Consumption;   Treatment Adverse Effect
    Intervention:   Behavioral: DOTS Adherence Monitoring
    Sponsors:   Boston Medical Center;   Medical Research Council, South Africa;   Boston University;   University of Cape Town;   National Institute of Allergy and Infectious Diseases (NIAID)
    Recruiting

  • Conditions:   Alcohol Drinking;   Alcohol Drinking Related Problems
    Interventions:   Behavioral: Retrieval-extinction;   Behavioral: Extinction;   Behavioral: Retrieval
    Sponsor:   National Institute on Drug Abuse (NIDA)
    Recruiting

  • Condition:   Alcohol Use
    Intervention:   Behavioral: Brief Negotiational Intervention
    Sponsors:   Duke University;   Kilimanjaro Christian Medical Centre, Tanzania;   John E. Fogarty International Center (FIC)
    Not yet recruiting

  • Condition:   Alcohol Withdrawal
    Interventions:   Drug: Ketamine;   Drug: Dexmedetomidine;   Drug: Normal saline
    Sponsor:   University of Colorado, Denver
    Not yet recruiting

  • Conditions:   Attention Deficit Hyperactivity Disorder;   Alcohol-Related Disorders;   Substance-Related Disorders
    Interventions:   Behavioral: SUCCEEDS Program;   Behavioral: Living a Healthy College Lifestyle
    Sponsors:   University of Maryland;   University of Memphis
    Recruiting

  • Condition:   Patient Adherence, Chronic Hepatitis C, Alcohol-related Disorders
    Intervention:   Behavioral: VBMI
    Sponsors:   G.V. (Sonny) Montgomery VA Medical Center;   Merck Sharp & Dohme Corp.
    Recruiting

  • Conditions:   Posttraumatic Stress Disorder;   Alcohol Use Disorders
    Intervention:   Behavioral: Brief Cognitive Therapy
    Sponsors:   University of Washington;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Drinking Behavior;   Risky Drinking
    Interventions:   Behavioral: SMI + I;   Behavioral: SMI
    Sponsors:   University of Michigan;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Condition:   Alcoholic Hepatitis (AH)
    Interventions:   Drug: Selonsertib;   Drug: Prednisolone;   Drug: Placebo
    Sponsor:   Gilead Sciences
    Recruiting

  • Conditions:   HIV Infection;   Alcohol Use;   Smoking
    Interventions:   Drug: Varenicline;   Drug: Cytisine;   Drug: Nicotine Replacement Therapy;   Drug: Varenicline Placebo;   Drug: Cytisine Placebo;   Drug: Nicotine Replacement Therapy Placebo
    Sponsors:   Boston Medical Center;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Traumatic Brain Injury (TBI);   Hazardous and Harmful Alcohol Use
    Interventions:   Behavioral: Medical Management Counseling;   Drug: N-acetylcysteine;   Drug: Placebo
    Sponsors:   University of California, San Francisco;   United States Department of Defense;   Northern California Institute of Research and Education;   San Francisco Veterans Affairs Medical Center;   Institute for Translational Neuroscience
    Recruiting

  • Condition:   Obesity
    Interventions:   Other: Oral Alcohol challenge test Alcohol visit first;   Other: Oral Alcohol challenge test Placebo visit first;   Other: Intravenous Alcohol Challenge Test (Clamp);   Other: Intravenous Alcohol Self-administration Test
    Sponsors:   University of Illinois at Urbana-Champaign;   Carle Foundation Hospital
    Recruiting

  • Condition:   Wernicke-Korsakoff Syndrome
    Intervention:   Drug: Thiamine Hydrochloride
    Sponsor:   Menzies School of Health Research
    Recruiting

  • Condition:   HIV Infection
    Interventions:   Drug: ART initiation at time of HIV diagnosis;   Drug: ART at 24 weeks
    Sponsors:   Fred Hutchinson Cancer Research Center;   University of California, San Francisco;   University of Washington;   Asociación Civil Impacta Salud y Educación, Peru;   Université de Montréal;   Seattle Children's Hospital
    Recruiting

  • Condition:   Alcohol Use Disorder
    Intervention:   Drug: Disulfiram
    Sponsor:   New York State Psychiatric Institute
    Recruiting

  • Condition:   Alcoholic Hepatitis
    Interventions:   Drug: Standard of care + pegfiltrastim;   Drug: Standard of care
    Sponsors:   Timothy Morgan, MD;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Condition:   Alcoholism
    Interventions:   Drug: Oxytocin;   Other: Placebo
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Not yet recruiting

  • Conditions:   Pain;   Opiates;   Alcohol Drinking
    Interventions:   Behavioral: Prevention Intervention;   Behavioral: Brief Intervention
    Sponsors:   University of Pennsylvania;   United States Department of Defense;   Corporal Michael J. Crescenz VA Medical Center;   Medical University of South Carolina;   VA Pittsburgh Healthcare System
    Recruiting

  • Conditions:   Cannabis;   Alcohol Effect;   Driving Under the Influence of Alcohol and Other Drugs
    Interventions:   Drug: Active Dronabinol;   Drug: Placebo;   Drug: Active Ethanol
    Sponsor:   Yale University
    Recruiting

  • Conditions:   Cannabis;   Alcohol Effect;   Driving Under the Influence of Alcohol and Other Drugs
    Interventions:   Drug: Active inhaled delta-9-THC;   Drug: Placebo;   Drug: Active Oral Ethanol
    Sponsor:   Yale University
    Recruiting

  • Conditions:   Obesity;   Smoking Cessation;   Alcoholism
    Interventions:   Drug: Exenatide;   Biological: Desacyl ghrelin;   Biological: Saline
    Sponsor:   Imperial College London
    Recruiting

  • Condition:   Alcohol Abuse
    Interventions:   Behavioral: ACHESS;   Behavioral: TMC
    Sponsor:   University of Pennsylvania
    Recruiting

  • Condition:   Alcoholism
    Interventions:   Drug: PF-05190457;   Behavioral: MI-VF;   Other: Placebo;   Other: Counseling
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Condition:   Alcohol Use Disorder Cognitive Decline
    Intervention:   Behavioral: Cognitive Remediation Training
    Sponsor:   VA Office of Research and Development
    Recruiting

  • Condition:   Alcohol Consumption
    Interventions:   Drug: Placebo;   Drug: 10 mg Obeticholic Acid (OCA)
    Sponsors:   Suthat Liangpunsakul;   National Institute on Alcohol Abuse and Alcoholism (NIAAA);   Intercept Pharmaceuticals
    Recruiting

  • Conditions:   Cardiovascular Disease (CVD);   Hypertension;   Hyperlipemia;   Obesity
    Intervention:   Other: Community-based peer health coach intervention
    Sponsor:   VA Office of Research and Development
    Recruiting

  • Conditions:   Healthy Controls;   Alcohol Use Disorder
    Interventions:   Drug: Placebo;   Drug: Oxytocin
    Sponsor:   University of Utah
    Recruiting

  • Condition:   Alcohol Drinking
    Interventions:   Drug: Nalmefene;   Other: Placebo
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Coronary; Ischemic;   Arrhythmias, Cardiac;   Heart Failure;   Peripheral Vascular Diseases;   Dementia;   Stroke;   Pulmonary Disease, Chronic Obstructive;   Respiratory Insufficiency;   Alcoholism;   Cancer;   Diabetes;   Renal Insufficiency
    Interventions:   Procedure: OPTI-AGED;   Procedure: Usual Care
    Sponsor:   Centre Hospitalier Universitaire de Saint Etienne
    Recruiting

  • Condition:   Alcohol Dependence
    Interventions:   Device: Multi-method Neuroendocrine and Neuroimaging Procedure Scan 1;   Device: Multi-method Neuroendocrine and Neuroimaging Procedure Scan 2
    Sponsor:   Yale University
    Recruiting

  • Condition:   Alcohol Use Disorder
    Intervention:   Drug: Baclofen
    Sponsors:   University Hospital, Lille;   Région Nord-Pas de Calais, France;   Groupement Interrégional de Recherche Clinique et d'Innovation
    Recruiting

  • Condition:   Acute Alcoholic Hepatitis
    Interventions:   Biological: ELAD System;   Other: Standard of Care (Control)
    Sponsor:   Vital Therapies, Inc.
    Recruiting

  • Conditions:   Alcohol Consumption;   HIV;   Motivation
    Interventions:   Behavioral: Motivational Interviewing;   Other: Questionnaire assessment;   Other: Neurocognitive assessments;   Other: Blood specimens
    Sponsors:   University of Florida;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Condition:   Alcohol Dependence
    Intervention:  
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Condition:   Substance Use Disorder
    Interventions:   Behavioral: Resonance Breathing;   Behavioral: Non-Resonance Breathing
    Sponsors:   Rutgers, The State University of New Jersey;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Alcohol-Related Disorders;   Alcohol Use Disorders;   Alcohol Drinking;   Alcoholism;   Alcohol Abuse
    Interventions:   Behavioral: Brief Advice;   Behavioral: Motivational Interviewing;   Behavioral: Behavioral Self-Control Training
    Sponsors:   Northwell Health;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Posttraumatic Stress Disorder;   Alcohol Use Disorders
    Interventions:   Drug: doxazosin;   Drug: placebo
    Sponsors:   VA Office of Research and Development;   Medical University of South Carolina;   Consortium to Alleviate PTSD
    Recruiting

  • Conditions:   Alcohol Use;   Drug Use;   Diagnostic Self Evaluation;   Gonorrhea;   Unprotected Sex;   Chlamydia;   Trichomonas
    Interventions:   Behavioral: Project EMPWR;   Other: Optimized Standard Care (OSC)
    Sponsor:   Johns Hopkins Bloomberg School of Public Health
    Recruiting

  • Conditions:   Major Depressive Disorder;   Alcohol Use Disorder
    Interventions:   Drug: Ketamine + Naltrexone;   Drug: Ketamine + Placebo;   Drug: Placebo (psychoactive placebo midazolam) + Placebo
    Sponsor:   VA Office of Research and Development
    Recruiting

  • Conditions:   Bipolar Disorder;   Anxious Disorder;   Alcohol Dependence
    Interventions:   Behavioral: Cognitive and Behavior Therapy (CBT);   Behavioral: Mindfulness Based Cognitive Therapy (MBCT)
    Sponsor:   Centre Hospitalier St Anne
    Recruiting

  • Conditions:   Alcohol Dependence;   Alcohol Use Disorder
    Intervention:   Drug: XR-NTX+CM (Extended-Release Naltrexone plus Care Management)
    Sponsors:   New York University School of Medicine;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Condition:   Alcohol Abuse
    Intervention:   Behavioral: Youth Access
    Sponsor:   Oregon Research Institute
    Recruiting

  • Conditions:   Fear;   Stress;   Alcohol Dependence
    Intervention:  
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Suicide;   Alcohol Drinking
    Intervention:   Behavioral: motivational enhancement therapy
    Sponsors:   Boston Children’s Hospital;   American Foundation for Suicide Prevention
    Recruiting

  • Condition:   Alcoholic Hepatitis
    Interventions:   Drug: Bovine Colostrum;   Drug: Placebo
    Sponsor:   Dayanand Medical College and Hospital
    Not yet recruiting

  • Condition:   Alcoholism
    Interventions:   Behavioral: Motivational Enhancement Therapy;   Behavioral: Cognitive Behavioral Therapy;   Other: FC Assessment;   Other: IB Assessment
    Sponsors:   Rutgers, The State University of New Jersey;   Syracuse University;   Pacific Institute for Research and Evaluation;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Cannabis;   Alcohol Effect;   Driving Under the Influence of Alcohol and Other Drugs
    Interventions:   Drug: Active delta-9-THC;   Drug: Placebo;   Drug: Active Ethanol
    Sponsor:   Yale University
    Recruiting

  • Condition:   Alcohol Use Disorder
    Interventions:   Drug: Zonisamide;   Drug: Placebo
    Sponsor:   VA Office of Research and Development
    Recruiting

  • Conditions:   Alcoholism;   Attention Deficit Disorder With Hyperactivity
    Intervention:   Behavioral: cognitive and psychiatric assessment
    Sponsors:   University Hospital, Lille;   Institute for Scientific Research on Beverages (France)
    Recruiting

  • Condition:   Alcohol Use Disorder
    Interventions:   Drug: Ondansetron;   Drug: Placebo
    Sponsors:   University of Maryland;   University of Pennsylvania
    Recruiting

  • Condition:   Alcoholism
    Interventions:   Drug: Topiramate;   Behavioral: Medical Management;   Drug: Inactive Placebo
    Sponsors:   University of Pennsylvania;   National Institute on Alcohol Abuse and Alcoholism (NIAAA);   National Institutes of Health (NIH);   Department of Health and Human Services;   Corporal Michael J. Crescenz VA Medical Center
    Recruiting

  • Condition:   Alcohol Dependence
    Intervention:   Other: Alcohol administration
    Sponsor:   University of Maryland
    Recruiting

  • Conditions:   Substance-Related Disorders;   Human Immunodeficiency Virus;   Alcoholism
    Interventions:   Behavioral: Soccer League (SL);   Behavioral: Soccer League/Vocational Training (SL-V)
    Sponsors:   University of California, Los Angeles;   National Institute on Drug Abuse (NIDA)
    Recruiting

  • Condition:   Alcoholism
    Intervention:   Behavioral: Cognitive Behavioral Coping Skills Therapy
    Sponsor:   New York State Psychiatric Institute
    Recruiting

  • Conditions:   HIV;   Hepatitis C
    Interventions:   Behavioral: Motivational Interviewing;   Behavioral: Brief Advice
    Sponsor:   Butler Hospital
    Recruiting

  • Conditions:   Human Immunodeficiency Virus;   HBV;   Fibrosis, Liver;   Cirrhosis, Liver;   Hepatocellular Carcinoma;   Hepatitis Delta Virus;   Alcoholic Hepatitis
    Intervention:   Drug: Anti-HIV Agents
    Sponsors:   University of Alabama at Birmingham;   John E. Fogarty International Center (FIC);   National Institutes of Health (NIH)
    Recruiting

  • Condition:   Alcohol Use Disorders
    Intervention:   Behavioral: Cue Exposure Treatment
    Sponsor:   University of Southern Denmark
    Recruiting

  • Conditions:   Infection;   Alcohol Abuse;   Drugs of Abuse;   Lung Injury
    Intervention:   Other: Characterize alcohol and drug use
    Sponsors:   University of Colorado, Denver;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Condition:   Risk Reduction Behavior
    Intervention:  
    Sponsor:   National Cancer Institute (NCI)
    Recruiting

  • Condition:   Alcohol Use Disorders
    Interventions:   Behavioral: Intensive Motivational Interviewing;   Behavioral: Single session of Motivational Interviewing
    Sponsor:   Public Health Institute, California
    Recruiting

  • Condition:   Hepatitis
    Intervention:  
    Sponsor:   Basildon and Thurrock University Hospitals NHS Foundation Trust
    Recruiting

  • Conditions:   Alcoholic Hepatitis;   Alcoholic Liver Disease
    Interventions:   Drug: Amoxicillin;   Drug: Placebo;   Drug: Prednisolone
    Sponsors:   University Hospital, Lille;   Ministry of Health, France
    Recruiting

  • Conditions:   Alcohol Use Disorders;   Stress Disorders, Posttraumatic;   Combat Disorders
    Interventions:   Drug: prazosin hydrochloride;   Drug: placebo
    Sponsors:   Seattle Institute for Biomedical and Clinical Research;   United States Department of Defense;   VA Puget Sound Health Care System
    Recruiting

  • Conditions:   AOD Use, Abuse, and Dependence;   Depression
    Interventions:   Behavioral: MET/CBT-12;   Behavioral: CBT-D;   Other: D-TAU
    Sponsors:   Duke University;   UConn Health;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Condition:   Alcoholism
    Intervention:  
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Alcoholism;   Substance-related Disorders;   Dual Diagnosis
    Interventions:   Behavioral: Group Motivational Interviewing (GMI);   Behavioral: Control Treatment Condition (CT)
    Sponsor:   VA Office of Research and Development
    Recruiting

  • Condition:   Alcoholism
    Interventions:   Device: MRI;   Drug: C-11PBR28;   Drug: F-18FDG
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Condition:   Alcohol Dependence
    Interventions:   Drug: Minocycline;   Drug: Placebo (for Minocycline)
    Sponsors:   Yale University;   United States Department of Defense
    Recruiting

  • Conditions:   Alcohol Dependence;   Alcohol Use Disorders;   Alcohol Abuse;   Alcoholism
    Interventions:   Drug: Mifepristone 1200 mg daily;   Behavioral: Standardized behavioral therapy;   Drug: Mifepristone 600 mg daily;   Drug: Placebo
    Sponsors:   The Scripps Research Institute;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Alcohol Use Disorder;   Eligible to go Into the MRI Scanner;   Short-term Abstinence From Alcohol Use (2 Week Abstinent)
    Intervention:   Device: Transcranial Direct Current Stimulation (tDCS)
    Sponsor:   University of Minnesota - Clinical and Translational Science Institute
    Recruiting

  • Condition:   Alcohol Drinking
    Interventions:   Drug: Guanfacine 3mg/day;   Drug: Guanfacine 1.5mg/day;   Drug: Placebo
    Sponsors:   Yale University;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Condition:   Obesity
    Intervention:  
    Sponsor:   University of Missouri-Columbia
    Recruiting

  • Conditions:   Alcohol Use Disorder;   Contingency Management
    Interventions:   Behavioral: Prize Contingency Management for Alcohol Abstinence;   Behavioral: Standard Care
    Sponsors:   UConn Health;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Magnetic Resonance Imaging;   Major Depression;   Alcoholism
    Interventions:   Drug: Ketamine;   Other: Alcohol Infusion
    Sponsor:   National Institute of Mental Health (NIMH)
    Recruiting

  • Conditions:   Evaluating NIAAA's Alcohol Screener;   Evaluating a Brief Intervention
    Interventions:   Behavioral: Brief Intervention;   Behavioral: Brief Intervention with Coaching;   Behavioral: Treatment as Usual
    Sponsors:   University of Rhode Island;   Brown University
    Recruiting

  • Conditions:   Alcohol Dependence;   Alcohol Drinking;   Alcoholism
    Intervention:  
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Alcohol Dependence;   Alcohol Drinking;   Alcohol-Related Disorders;   Alcoholism;   Brain Mapping
    Intervention:  
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Alcoholism;   fMRI;   Rewarding Mediating System
    Intervention:  
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Condition:   Alcohol Drinking
    Interventions:   Drug: Topiramate;   Drug: Placebo
    Sponsor:   University of Pennsylvania
    Recruiting

  • Condition:   Alcohol Dependence
    Interventions:   Drug: Psilocybin;   Drug: Diphenhydramine;   Behavioral: Motivational Enhancement and Taking Action (META)
    Sponsors:   New York University School of Medicine;   Heffter Research Institute;   University of New Mexico
    Recruiting

  • Condition:   Alcoholic Hepatitis
    Intervention:  
    Sponsors:   University of North Carolina, Chapel Hill;   National Institute on Alcohol Abuse and Alcoholism (NIAAA);   University of Wisconsin, Madison;   King's College London;   Veterans Medical Research Foundation;   Universidad Autonoma de Nuevo Leon;   Hospital Vall d'Hebron
    Recruiting

  • Conditions:   Unhealthy Alcohol Use;   Alcohol Use Disorder;   Alcohol Disorders
    Intervention:   Behavioral: Relational Agent Intervention
    Sponsors:   VA Office of Research and Development;   Northeastern University;   Boston University
    Recruiting

  • Conditions:   Atrial Fibrillation;   Alcohol
    Interventions:   Drug: Ethanol;   Drug: Placebo
    Sponsor:   University of California, San Francisco
    Recruiting

  • Conditions:   Alcohol Use;   AA Attendance;   Sexual Risk Behavior
    Intervention:   Other: Introduction to AA volunteer
    Sponsor:   Butler Hospital
    Recruiting

  • Condition:   Hepatitis, Alcoholic
    Interventions:   Drug: IMM 124-E (Hyperimmune Bovine Colostrum);   Drug: Placebo (High protein milk powder)
    Sponsors:   Virginia Commonwealth University;   National Institute on Alcohol Abuse and Alcoholism (NIAAA);   Immuron Ltd.
    Recruiting

  • Condition:   Alcohol Dependence
    Interventions:   Drug: XR-NTX (Extended-Release Naltrexone);   Drug: Oral Naltrexone (O-NTX)
    Sponsor:   New York University School of Medicine
    Recruiting

  • Conditions:   Alcohol Dependence;   Post-Traumatic Stress Disorder (PTSD)
    Interventions:   Behavioral: Enhanced-Cognitive Processing Therapy-C (E-CPT-C);   Drug: Zonisamide;   Drug: Placebo
    Sponsors:   Yale University;   United States Department of Defense
    Recruiting

  • Condition:   Alcohol Dependence
    Interventions:   Drug: GET 73;   Drug: inactive ingredients capsule
    Sponsors:   Laboratorio Farmaceutico Ct S.r.l.;   Voisin Consulting, Inc.;   Latis Srl;   Quotient Bioresearch Ltd
    Recruiting

  • Conditions:   Rare Disorders;   Undiagnosed Disorders;   Disorders of Unknown Prevalence;   Cornelia De Lange Syndrome;   Prenatal Benign Hypophosphatasia;   Perinatal Lethal Hypophosphatasia;   Odontohypophosphatasia;   Adult Hypophosphatasia;   Childhood-onset Hypophosphatasia;   Infantile Hypophosphatasia;   Hypophosphatasia;   Kabuki Syndrome;   Bohring-Opitz Syndrome;   Narcolepsy Without Cataplexy;   Narcolepsy-cataplexy;   Hypersomnolence Disorder;   Idiopathic Hypersomnia Without Long Sleep Time;   Idiopathic Hypersomnia With Long Sleep Time;   Idiopathic Hypersomnia;   Kleine-Levin Syndrome;   Kawasaki Disease;   Leiomyosarcoma;   Leiomyosarcoma of the Corpus Uteri;   Leiomyosarcoma of the Cervix Uteri;   Leiomyosarcoma of Small Intestine;   Acquired Myasthenia Gravis;   Addison Disease;   Hyperacusis (Hyperacousis);   Juvenile Myasthenia Gravis;   Transient Neonatal Myasthenia Gravis;   Williams Syndrome;   Lyme Disease;   Myasthenia Gravis;   Marinesco Sjogren Syndrome(Marinesco-Sjogren Syndrome);   Isolated Klippel-Feil Syndrome;   Frasier Syndrome;   Denys-Drash Syndrome;   Beckwith-Wiedemann Syndrome;   Emanuel Syndrome;   Isolated Aniridia;   Beckwith-Wiedemann Syndrome Due to Paternal Uniparental Disomy of Chromosome 11;   Beckwith-Wiedemann Syndrome Due to Imprinting Defect of 11p15;   Beckwith-Wiedemann Syndrome Due to 11p15 Translocation/Inversion;   Beckwith-Wiedemann Syndrome Due to 11p15 Microduplication;   Beckwith-Wiedemann Syndrome Due to 11p15 Microdeletion;   Axenfeld-Rieger Syndrome;   Aniridia-intellectual Disability Syndrome;   Aniridia - Renal Agenesis - Psychomotor Retardation;   Aniridia - Ptosis - Intellectual Disability - Familial Obesity;   Aniridia - Cerebellar Ataxia - Intellectual Disability;   Aniridia - Absent Patella;   Aniridia;   Peters Anomaly - Cataract;   Peters Anomaly;   Potocki-Shaffer Syndrome;   Silver-Russell Syndrome Due to Maternal Uniparental Disomy of Chromosome 11;   Silver-Russell Syndrome Due to Imprinting Defect of 11p15;   Silver-Russell Syndrome Due to 11p15 Microduplication;   Syndromic Aniridia;   WAGR Syndrome;   Wolf-Hirschhorn Syndrome;   4p16.3 Microduplication Syndrome;   4p Deletion Syndrome, Non-Wolf-Hirschhorn Syndrome;   Autosomal Recessive Stickler Syndrome;   Stickler Syndrome Type 2;   Stickler Syndrome Type 1;   Stickler Syndrome;   Mucolipidosis Type 4;   X-linked Spinocerebellar Ataxia Type 4;   X-linked Spinocerebellar Ataxia Type 3;   X-linked Intellectual Disability - Ataxia - Apraxia;   X-linked Progressive Cerebellar Ataxia;   X-linked Non Progressive Cerebellar Ataxia;   X-linked Cerebellar Ataxia;   Vitamin B12 Deficiency Ataxia;   Toxic Exposure Ataxia;   Unclassified Autosomal Dominant Spinocerebellar Ataxia;   Thyroid Antibody Ataxia;   Sporadic Adult-onset Ataxia of Unknown Etiology;   Spinocerebellar Ataxia With Oculomotor Anomaly;   Spinocerebellar Ataxia With Epilepsy;   Spinocerebellar Ataxia With Axonal Neuropathy Type 2;   Spinocerebellar Ataxia Type 8;   Spinocerebellar Ataxia Type 7;   Spinocerebellar Ataxia Type 6;   Spinocerebellar Ataxia Type 5;   Spinocerebellar Ataxia Type 4;   Spinocerebellar Ataxia Type 37;   Spinocerebellar Ataxia Type 36;   Spinocerebellar Ataxia Type 35;   Spinocerebellar Ataxia Type 34;   Spinocerebellar Ataxia Type 32;   Spinocerebellar Ataxia Type 31;   Spinocerebellar Ataxia Type 30;   Spinocerebellar Ataxia Type 3;   Spinocerebellar Ataxia Type 29;   Spinocerebellar Ataxia Type 28;   Spinocerebellar Ataxia Type 27;   Spinocerebellar Ataxia Type 26;   Spinocerebellar Ataxia Type 25;   Spinocerebellar Ataxia Type 23;   Spinocerebellar Ataxia Type 22;   Spinocerebellar Ataxia Type 21;   Spinocerebellar Ataxia Type 20;   Spinocerebellar Ataxia Type 2;   Spinocerebellar Ataxia Type 19/22;   Spinocerebellar Ataxia Type 18;   Spinocerebellar Ataxia Type 17;   Spinocerebellar Ataxia Type 16;   Spinocerebellar Ataxia Type 15/16;   Spinocerebellar Ataxia Type 14;   Spinocerebellar Ataxia Type 13;   Spinocerebellar Ataxia Type 12;   Spinocerebellar Ataxia Type 11;   Spinocerebellar Ataxia Type 10;   Spinocerebellar Ataxia Type 1 With Axonal Neuropathy;   Spinocerebellar Ataxia Type 1;   Spinocerebellar Ataxia - Unknown;   Spinocerebellar Ataxia - Dysmorphism;   Non Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature;   Spectrin-associated Autosomal Recessive Cerebellar Ataxia;   Spasticity-ataxia-gait Anomalies Syndrome;   Spastic Ataxia With Congenital Miosis;   Spastic Ataxia - Corneal Dystrophy;   Spastic Ataxia;   Rare Hereditary Ataxia;   Rare Ataxia;   Recessive Mitochondrial Ataxia Syndrome;   Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature;   Posterior Column Ataxia - Retinitis Pigmentosa;   Post-Stroke Ataxia;   Post-Head Injury Ataxia;   Post Vaccination Ataxia;   Polyneuropathy - Hearing Loss - Ataxia - Retinitis Pigmentosa - Cataract;   Muscular Atrophy - Ataxia - Retinitis Pigmentosa - Diabetes Mellitus;   Non-progressive Cerebellar Ataxia With Intellectual Disability;   Non-hereditary Degenerative Ataxia;   Paroxysmal Dystonic Choreathetosis With Episodic Ataxia and Spasticity;   Olivopontocerebellar Atrophy - Deafness;   NARP Syndrome;   Myoclonus - Cerebellar Ataxia - Deafness;   Multiple System Atrophy, Parkinsonian Type;   Multiple System Atrophy, Cerebellar Type;   Multiple System Atrophy;   Maternally-inherited Leigh Syndrome;   Machado-Joseph Disease Type 3;   Machado-Joseph Disease Type 2;   Machado-Joseph Disease Type 1;   Lethal Ataxia With Deafness and Optic Atrophy;   Leigh Syndrome;   Leukoencephalopathy With Mild Cerebellar Ataxia and White Matter Edema;   Leukoencephalopathy - Ataxia - Hypodontia - Hypomyelination;   Leigh Syndrome With Nephrotic Syndrome;   Leigh Syndrome With Leukodystrophy;   Leigh Syndrome With Cardiomyopathy;   Late-onset Ataxia With Dementia;   Intellectual Disability-hyperkinetic Movement-truncal Ataxia Syndrome;   Infection or Post Infection Ataxia;   Infantile-onset Autosomal Recessive Nonprogressive Cerebellar Ataxia;   Infantile Onset Spinocerebellar Ataxia;   GAD Ataxia;   Hereditary Episodic Ataxia;   Gliadin/Gluten Ataxia;   Friedreich Ataxia;   Fragile X-associated Tremor/Ataxia Syndrome;   Familial Paroxysmal Ataxia;   Exposure to Medications Ataxia;   Episodic Ataxia With Slurred Speech;   Episodic Ataxia Unknown Type;   Episodic Ataxia Type 7;   Episodic Ataxia Type 6;   Episodic Ataxia Type 5;   Episodic Ataxia Type 4;   Episodic Ataxia Type 3;   Episodic Ataxia Type 1;   Epilepsy and/or Ataxia With Myoclonus as Major Feature;   Early-onset Spastic Ataxia-neuropathy Syndrome;   Early-onset Progressive Neurodegeneration - Blindness - Ataxia - Spasticity;   Early-onset Cerebellar Ataxia With Retained Tendon Reflexes;   Early-onset Ataxia With Dementia;   Childhood-onset Autosomal Recessive Slowly Progressive Spinocerebellar Ataxia;   Dilated Cardiomyopathy With Ataxia;   Cataract - Ataxia - Deafness;   Cerebellar Ataxia, Cayman Type;   Cerebellar Ataxia With Peripheral Neuropathy;   Cerebellar Ataxia - Hypogonadism;   Cerebellar Ataxia - Ectodermal Dysplasia;   Cerebellar Ataxia - Areflexia - Pes Cavus - Optic Atrophy - Sensorineural Hearing Loss;   Brain Tumor Ataxia;   Brachydactyly - Nystagmus - Cerebellar Ataxia;   Benign Paroxysmal Tonic Upgaze of Childhood With Ataxia;   Autosomal Recessive Syndromic Cerebellar Ataxia;   Autosomal Recessive Spastic Ataxia With Leukoencephalopathy;   Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay;   Autosomal Recessive Spastic Ataxia - Optic Atrophy - Dysarthria;   Autosomal Recessive Spastic Ataxia;   Autosomal Recessive Metabolic Cerebellar Ataxia;   Autosomal Dominant Spinocerebellar Ataxia Due to Repeat Expansions That do Not Encode Polyglutamine;   Autosomal Recessive Ataxia, Beauce Type;   Autosomal Recessive Ataxia Due to Ubiquinone Deficiency;   Autosomal Recessive Ataxia Due to PEX10 Deficiency;   Autosomal Recessive Degenerative and Progressive Cerebellar Ataxia;   Autosomal Recessive Congenital Cerebellar Ataxia Due to MGLUR1 Deficiency;   Autosomal Recessive Congenital Cerebellar Ataxia Due to GRID2 Deficiency;   Autosomal Recessive Congenital Cerebellar Ataxia;   Autosomal Recessive Cerebellar Ataxia-pyramidal Signs-nystagmus-oculomotor Apraxia Syndrome;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to WWOX Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to TUD Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to KIAA0226 Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome;   Autosomal Recessive Cerebellar Ataxia With Late-onset Spasticity;   Autosomal Recessive Cerebellar Ataxia Due to STUB1 Deficiency;   Autosomal Recessive Cerebellar Ataxia Due to a DNA Repair Defect;   Autosomal Recessive Cerebellar Ataxia - Saccadic Intrusion;   Autosomal Recessive Cerebellar Ataxia - Psychomotor Retardation;   Autosomal Recessive Cerebellar Ataxia - Blindness - Deafness;   Autosomal Recessive Cerebellar Ataxia;   Autosomal Dominant Spinocerebellar Ataxia Due to a Polyglutamine Anomaly;   Autosomal Dominant Spinocerebellar Ataxia Due to a Point Mutation;   Autosomal Dominant Spinocerebellar Ataxia Due to a Channelopathy;   Autosomal Dominant Spastic Ataxia Type 1;   Autosomal Dominant Spastic Ataxia;   Autosomal Dominant Optic Atrophy;   Ataxia-telangiectasia Variant;   Ataxia-telangiectasia;   Autosomal Dominant Cerebellar Ataxia, Deafness and Narcolepsy;   Autosomal Dominant Cerebellar Ataxia Type 4;   Autosomal Dominant Cerebellar Ataxia Type 3;   Autosomal Dominant Cerebellar Ataxia Type 2;   Autosomal Dominant Cerebellar Ataxia Type 1;   Autosomal Dominant Cerebellar Ataxia;   Ataxia-telangiectasia-like Disorder;   Ataxia-intellectual Disability-oculomotor Apraxia-cerebellar Cysts Syndrome;   Ataxia-deafness-intellectual Disability Syndrome;   Ataxia With Vitamin E Deficiency;   Ataxia With Dementia;   Ataxia Neuropathy Spectrum;   Ataxia - Tapetoretinal Degeneration;   Ataxia - Photosensitivity - Short Stature;   Ataxia - Pancytopenia;   Ataxia - Oculomotor Apraxia Type 1;   Ataxia - Hypogonadism - Choroidal Dystrophy;   Ataxia - Other;   Ataxia - Genetic Diagnosis - Unknown;   Acquired Ataxia;   Adult-onset Autosomal Recessive Cerebellar Ataxia;   Alcohol Related Ataxia;   Multiple Endocrine Neoplasia;   Multiple Endocrine Neoplasia Type II;   Multiple Endocrine Neoplasia Type 1;   Multiple Endocrine Neoplasia Type 2;   Multiple Endocrine Neoplasia, Type IV;   Multiple Endocrine Neoplasia, Type 3;   Multiple Endocrine Neoplasia (MEN) Syndrome;   Multiple Endocrine Neoplasia Type 2B;   Multiple Endocrine Neoplasia Type 2A;   Atypical Hemolytic Uremic Syndrome;   Atypical HUS;   Wiedemann-Steiner Syndrome;   Breast Implant-Associated Anaplastic Large Cell Lymphoma;   Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA);   Hemophagocytic Lymphohistiocytosis;   Behcet's Disease
    Intervention:  
    Sponsors:   Sanford Health;   National Ataxia Foundation;   International WAGR Syndrome Association;   4p- Support Group;   ML4 Foundation;   Cornelia de Lange Syndrome Foundation;   Stickler Involved People;   Kawasaki Disease Foundation;   Klippel-Feil Syndrome Alliance;   Klippel-Feil Syndrome Freedom;   Hyperacusis Research Limited;   Hypersomnia Foundation;   Kabuki Syndrome Network;   Kleine-Levin Syndrome Foundation;   Leiomyosarcoma Direct Research Foundation;   Marinesco-Sjogren Syndrome Support Group;   Mucolipidosis Type IV (ML4) Foundation;   People with Narcolepsy 4 People with Narcolepsy (PWN4PWN);   Soft Bones Incorporated;   American Multiple Endocrine Neoplasia Support;   Atypical Hemolytic Uremic Syndrome Foundation;   All Things Kabuki;   Wiedemann-Steiner Syndrome Foundation;   Breast Implant Victim Advocates;   PROS Foundation;   American Behcet's Disease Association
    Recruiting

  • Conditions:   Hepatitis C;   Alcohol Abuse
    Interventions:   Other: Web-Based Brief Alcohol Intervention;   Other: Usual Care
    Sponsor:   VA Office of Research and Development
    Recruiting

  • Conditions:   Schizophrenia;   Cannabis Dependence;   Prodromal for Psychotic Illness;   Family History of Alcoholism
    Intervention:   Radiation: [11-C]OMAR
    Sponsors:   Yale University;   National Institute on Drug Abuse (NIDA);   National Institute of Mental Health (NIMH)
    Recruiting

  • Condition:   Alcohol Drinking
    Intervention:   Drug: Naltrexone
    Sponsor:   Yale University
    Recruiting

  • Conditions:   Liver Diseases, Alcoholic;   Alcoholism;   HIV;   Hepatitis C
    Interventions:   Other: Integrated Stepped Care (ISC);   Other: Treatment as Usual
    Sponsors:   Yale University;   National Institute on Alcohol Abuse and Alcoholism (NIAAA);   VA Office of Research and Development
    Recruiting

  • Conditions:   Carcinoma, Hepatocellular;   Liver Cirrhosis, Alcoholic;   Hepatitis, Alcoholic;   Hepatitis, Chronic;   Hepatitis, Viral, Human
    Intervention:  
    Sponsor:   National Cancer Institute (NCI)
    Recruiting

  • Condition:   Alcoholic Intoxication
    Interventions:   Drug: Alcohol;   Procedure: Self-Administration
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting


PaidClinicalTrials.orgPaidClinicalTrials.org